The Promise Of IQVIA One Home For Sites: A Site CEO's Perspective

By Dan Kearney, CEO, CNS Healthcare

With three decades in clinical research, I’ve seen technology evolve to streamline site operations and enhance sponsor oversight. Yet, one of the biggest challenges remains: the overwhelming fragmentation of clinical trial systems that sites must navigate daily. IQVIA’s One Home for Sites offers a promising solution, consolidating access into a single platform to simplify operations.

To clinical technology vendors and pharmaceutical sponsors — your participation is essential. One Home for Sites can only fulfill its potential with widespread adoption, enabling single sign-on and seamless access to essential tools.

Coming from a background in mental health counseling and hospital administration, I’ve seen how technology can both improve and complicate patient care. At CNS Healthcare, where we initiate around 100 new trials annually, our research staff juggles access to 15–17 different vendors per study — totaling 1,000 to 1,500 unique systems each year. Managing separate logins, training protocols, and platform requirements creates a heavy administrative burden, often requiring extra hours just to ensure technology doesn’t interfere with patient care.

For years, the industry has needed a unified system to streamline these processes. With One Home for Sites, that solution is finally here.